Related content

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment

By Mamori Satoshi   Suzuki Fumitaka   Hosaka Tetsuya   Akuta Norio   Someya Takashi   Kobayashi Masahiro   Tsubota Akihito   Suzuki Yoshiyuki   Saitoh Satoshi   Arase Yasuji   Ikeda Kenji   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 39, Iss. 8, 2004-08 ,pp. : 776-782

Springer Publishing Company

Access to resources Recommend Favorite

A dose-dependent controlled trial of human lymphoblastoid interferon for genotype 1b chronic hepatitis C associated with high HCV-RNA levels

By Komatsu M.   Ishii T.   Ono T.   Kuramitsu T.   Hoshino T.   Masamune O.   Yoshida T.   Yagisawa H.   Yamada N.  

International Hepatology Communications, Vol. 7, Iss. 2, 1997-06 ,pp. : 105-112

Elsevier

Access to resources Recommend Favorite

Retreatment with Interferon-Alpha and Ribavirin in Primary Interferon-Alpha Non-Responders with Chronic Hepatitis C

By  

Digestion, Vol. 61, Iss. 2, 2000-02 ,pp. : 90-97

Karger

Access to resources Recommend Favorite

The changes of serum soluble HLA-class I and CD8 concentrations during interferon treatment of chronic hepatitis C patients

By Hagihara M.   Shimura T.   Takebe K.   Munkhbat B.   Yamamoto K.   Hosoi K.   Kagawa T.   Watanabe N.   Matsuzaki S.   Tsuji K.  

International Hepatology Communications, Vol. 6, Iss. 6, 1997-03 ,pp. : 316-323

Elsevier

Access to resources Recommend Favorite

Interferon-Alpha in Combination with Ribavirin for the Treatment of Chronic Hepatitis C in Patients with Persistently Normal Aminotransferase Levels

By  

Digestion, Vol. 65, Iss. 2, 2002-05 ,pp. : 127-130

Karger

Access to resources Recommend Favorite